Showing results (191-200 of 322) with videos related to

Sort By:
Pageof 33
Molecular Oncology|September 28, 2018
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosisChiara Rossi, Roberta Zini, Sebastiano Rontauroli, et al.
Stem Cells (Dayton, Ohio)|September 23, 2006
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)Paola Guglielmelli, Roberta Zini, Costanza Bogani, et al.
Leukemia|April 15, 2018
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosisAyalew Tefferi, Paola Guglielmelli, Maura Nicolosi, et al.
British Journal of Haematology|September 9, 2009
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromesTamara Intermesoli, Federica Delaini, Sara Acerboni, et al.
Experimental Hematology|July 21, 2009
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTENCristina Cellai, Anna Laurenzana, Elisa Bianchi, et al.
Blood|June 16, 2012
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosisTiziano Barbui, Jürgen Thiele, Alessandra Carobbio, et al.
Hematological Oncology|July 5, 2021
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access studyFrancesco Passamonti, Vikas Gupta, Bruno Martino, et al.
Blood Cancer Journal|December 13, 2021
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosisPaola Guglielmelli, Giuseppe G Loscocco, Carmela Mannarelli, et al.
American Journal of Hematology|August 23, 2021
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patientsGiuseppe G Loscocco, Paola Guglielmelli, Naseema Gangat, et al.
Blood|April 15, 2011
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patientsAlessandra Carobbio, Juergen Thiele, Francesco Passamonti, et al.
Pageof 33